Pathology: non squamous - mNSCLC - L1 - all population; non squamous - mNSCLC - L1 - Wild Type (WT);
non squamous - mNSCLC - L1 - all population | non squamous - mNSCLC - L1 - Wild Type (WT) | ||
IMpower-130 (all population), 2019 | IMpower-130 (WT), 2019 | ||
atezolizumab plus carboplatin plus nab-paclitaxel | 2 | T1T0 | T1 |
carboplatin plus nab-paclitaxel | 0 | T0 |